Feldman Andrew D. sold $3.1M of CBRS

Feldman Andrew D. (CEO, President) sold 17,990 shares of Cerebras Systems Inc. (CBRS) at an average of $173.06 ($169.07–$184.73, $3.11M total) across 12 trades on 2026-06-25.

Original reporting
SEC EDGAR · Feldman Andrew D.
Published Jun 29, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The disclosure provides a concrete insider selling event (size, dates, price range, and post-transaction holdings), which may influence short-term sentiment but does not change the company’s fundamentals on its own.

02

Market read

Traders may monitor for follow-on insider activity or any concurrent company news, but this filing alone is unlikely to drive a durable repricing.

03

What to watch

The article does not state motivations, tax planning, or whether other insiders or the company have concurrent catalysts; traders should avoid over-weighting insider-sale narratives without corroborating news.

Relevance 6/10Novelty 4/10Timing: filed 2026-06-29 after trades on 2026-06-25

Background

The article is a SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems CEO Andrew Feldman sold about $3.11M of CBRS shares in an open-market Form 4, leaving 0 shares after the trades.

Expected impact

Near-term sentiment impact is likely limited, with any price reaction more dependent on broader tape and company-specific catalysts than this filing alone.

Evidence & confidence

The filing discloses transaction size, pricing range, and that holdings fell to zero, but it does not provide new operational, financial, or regulatory information.

Market effects

Minimal, as this is a single-company insider transaction without sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity or diversification, and the absence of a stated 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • Cerebras Systems Inc.

    Subject of the Form 4 insider sale by its CEO/President.

  • Andrew D. Feldman

    CEO and President who sold shares and reported 0 shares after the transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.